Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EQUISOCK: New Antiequine for Ankle

NCT07333768 is registered in ClinicalTrials.gov with University of Salamanca as lead sponsor.

NCT NCT07333768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07333768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EQUISOCK: New Antiequine for Ankle
Lead sponsor
University of Salamanca
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
December 31, 2026
Enrollment
4 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankle (ligaments); instability (old injury), ankle dorsiflexion, ankle equinus